Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands
about
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trialSystems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients.EGFR-TKIs versus taxanes agents in therapy for nonsmall-cell lung cancer patients: A PRISMA-compliant systematic review with meta-analysis and meta-regression.Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.Choroidal metastasis of non-small cell lung cancer that responded to gefitinib.Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.
P2860
Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Estimating quality adjusted pr ...... er patients in The Netherlands
@ast
Estimating quality adjusted pr ...... er patients in The Netherlands
@en
type
label
Estimating quality adjusted pr ...... er patients in The Netherlands
@ast
Estimating quality adjusted pr ...... er patients in The Netherlands
@en
prefLabel
Estimating quality adjusted pr ...... er patients in The Netherlands
@ast
Estimating quality adjusted pr ...... er patients in The Netherlands
@en
P2093
P2860
P356
P1476
Estimating quality adjusted pr ...... er patients in The Netherlands
@en
P2093
Anne-Marie C Dingemans
Bonne Biesma
Feike W van der Scheer
Franz M N H Schramel
Maria A de Peuter
Merel K Langenfeld
S Cora Verduyn
P2860
P2888
P356
10.1186/1477-7525-10-108
P577
2012-09-10T00:00:00Z
P5875
P6179
1030896292